GAUDIUMIVF share price, P/E, ROE & financials

On 6 Nov 2026, Gaudium IVF and Women Health was priced at ₹104.18, or 30.8× trailing earnings, against an industry P/E of 47.7×, and the shares are 36% below their 52-week high. Sales and net profit grew 33% and 22% a year over 3 years; its ROCE of 23% is the highest among the 7 largest Medical Care Facilities peers. Debt is 0.16× equity. It is a small-cap company with a market cap of ₹758 Cr, ranked 24th of 40 Medical Care Facilities companies by market cap; the shares rose 30% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹105.00
Day high: ₹105.53
Day low: ₹103.05
Prev. close: ₹105.57
Volume: 63.5K

Health check

4 good · 1 fair · 1 to check

ReturnsAhead
+29.8% over a year, better than 7 of 7 peers.
Price tagCheaper
P/E 30.8 vs industry 47.7.
GrowthStrong
Sales +33.1%, profit +21.8% a year over 3 years.
ProfitabilityStrong
ROCE 23.1% vs peer median 11.9%.
Balance sheetFair
Debt 0.16× equity, interest covered 10.2×, Piotroski 4 of 9.
Red flags2 to check
Quarterly profit down 42.3% on a year ago.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹758 Cr, #24 of 40 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹106 Cr · profit ₹23 Cr

Market cap: ₹758 Cr; Small cap
P/E: 30.8; Industry 47.7
Price to book: 4.27; Peers 8.06
Dividend yield: 0.00%
ROE: 24.6%; Peers 12.8%
ROCE: 23.1%; Peers 11.9%
Debt to equity: 0.16; Debt ₹25 Cr
EPS (TTM): ₹3.38; Face value ₹5
OPM (TTM): 33.2%; Net margin 21.9%
Sales growth: +9.1%; Latest quarter vs a year ago
Profit growth: −42.3%; Latest quarter vs a year ago
Price to sales: 7.16; EV/EBITDA 21.6

Strengths

Return on equity of 24.6%.
Return on capital employed of 23.1%.
Net margin of 21.9%.
P/E of 30.8 against an industry P/E of 47.7.
Positive operating cash flow in each of the last 4 years.

Risks to check

Quarterly profit down 42.3% on a year ago.
36% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Gaudium IVF and Women Health

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male…

Headquarters: New Delhi
Employees: 120
Sector: Healthcare
ISIN: INE0P8B01020
Website: gaudiumivfcentre.com

Price range

52 weeks

₹69.18₹163.18

Today

₹103.05₹105.53

Avg volume (3M): 2.2 L
1-year return: plus 29.8%
From 52-week high: minus 36.2%

Peers · Medical Care Facilities

Compare with peers Screen the whole industry

Company
APOLLOHOSPApollo Hospitals Enterprise	8,446.00	plus 0.90%	1,21,441	54.0	11.45	19.2%	22.5%	15.4%	14.8%	33.3%	0.24%	plus 7.2%
MAXHEALTHMax Healthcare Institute	934.00	plus 0.21%	90,909	66.1	8.03	12.6%	12.8%	26.8%	22.4%	9.3%	0.21%	minus 18.1%
MANIPALHOSManipal Health Enterprises	646.70	minus 1.61%	85,065	133.6	9.05	9.8%	9.2%	17.8%	–	–	0.00%	minus 3.0%
ASTERDMAster DM Quality Care	713.15	minus 0.89%	62,092	90.7	8.06	9.4%	9.7%	17.4%	15.7%	−3.0%	0.42%	plus 4.5%
FORTISFortis Healthcare	766.90	minus 6.45%	57,898	55.7	5.52	11.9%	10.4%	22.2%	13.3%	20.9%	0.13%	minus 19.6%
NHNarayana Hrudayalaya	1,903.00	minus 0.65%	38,650	44.7	7.73	11.4%	19.1%	18.5%	20.5%	9.9%	0.24%	plus 4.7%
MEDANTAGlobal Health	1,387.60	minus 0.15%	37,264	60.4	8.63	15.0%	15.2%	22.1%	17.2%	19.5%	0.04%	plus 11.2%
GAUDIUMIVFGaudium IVF and Women Health	104.18	minus 1.32%	758	30.8	4.27	23.1%	24.6%	33.2%	33.1%	21.8%	0.00%	plus 29.8%
Median of 7 peers	–	−0.65%	62,092	60.4	8.06	11.9%	12.8%	18.5%	16.5%	14.7%	0.21%	4.5%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
17.8	31.7	24.5	30.4	19.4
12.6	17.7	18	18.2	17
5.2	14	6.6	12.2	2.4
29.0%	44.2%	26.7%	40.1%	12.5%
0	−0.1	0.1	0.2	1.1
0.5	0.4	1.2	1.3	0.4
0.6	0.8	0.5	0.6	0.7
4	12.7	5	10.4	2.4
24.0%	26.0%	26.9%	19.8%	27.5%
3.1	9.4	3.6	8.4	1.8
0.39	–	0.50	1.34	0.25

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +33.1%
Profit CAGR 3Y: +21.8%
EPS CAGR 3Y: +28.2%
ROE: 24.6%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
44.2	47.9	70.7	104
–	+8.3%	+47.7%	+47.6%
24	28.1	41.7	66.3
20.2	19.7	29	38.1
45.7%	41.2%	41.0%	36.5%
−0.1	−0.2	−0	0.1
0.3	0.7	1.4	3.5
1.4	2.2	2	2.5
–	−0.1	−0.1	0
18.3	16.6	25.4	32.2
26.1%	38.0%	24.6%	23.9%
13.5	10.3	19.2	24.5
–	minus 23.7%	+85.8%	+27.6%
1.86	1.42	2.40	3.92

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
1	1	30.7	36.4
21.7	26	15.6	116
11.5	17.4	20.6	24.6
2.4	6.6	21.6	16.2
36.6	51	88.5	193
5.5	7.3	7.9	8.7
–	–	5	86.1
15.1	11.9	7.2	8.8
16	31.8	68.4	89.6
36.6	51	88.5	193

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
23.9	3.4	8.7	7.2
−15.6	−5.4	−15.2	−87.7
5.3	−1.2	1.8	82
13.5	−3.2	−4.6	1.6
−15.3	−2.8	−8.9	−6.7
8.6	0.7	−0.2	0.5
–	−6.4	–	–

Shareholding pattern

Source: NSE filings

NSE hasn’t returned a shareholding pattern for this company. Institutions hold about 0.0% (Yahoo estimate).

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you